RSS

immunotherapies

In this article, Frances Salisbury (partner) and Adam Gregory (associate) — European Patent Attorneys in the Life Sciences team at Mewburn Ellis — discuss innovation and IP of CAR-T therapies in more detail. more

, Opinion

The European Patent Office has issued a new patent to biotechnology company, CEL-SCI, for its lead investigational immunotherapy, which is undergoing a Phase III clinical trial for head and neck cancer. more

Technology

T-cell receptor (TCR) company, Immunocore, has announced it will receive $40 million investment from the Bill & Melinda Gates Foundation to accelerate development of its TCR-based therapeutics for infectious diseases. more

News

An integrated oncology platform from Crown Bioscience has helped to advance the preclinical development of a HERA-GITRL immunotherapy from Apogenix for non-small cell lung cancer (NSCLC) and head and neck cancer. more

Technology

CiMaas, a developer of cellular immunotherapy for cancer, and PharmaCell, a contract manufacturer for cellular therapies and regenerative medicine in Europe, are collaborating in the clinical development of CiMaas’ products. more

News

An immunotherapy clinical trial collaboration is to be undertaken by Immunocore and Eli Lilly and Company, exploring the use of Immunocore’s lead T-cell receptor-based investigational therapeutic, IMCgp100, in combination with Lilly’s galunisertib (L more

News

BioNTech RNA Pharmaceuticals and EUFETS will work with Siemens to produce a fully automated and digitalised production site, providing capacity for BioNTech’s personalised cancer vaccines to serve worldwide markets. more

News

TxCell, a biotechnology company developing personalised cell-based immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, will participate at the second French Life Sciences Days. more

News

As part of the agreement, BMS and Ono will jointly develop and commercialise Opdivo (nivolumab) and Yervoy (ipilimumab) across a broad range of tumour types. more